Sintx Technologies Files Amendment to S-1 Registration Statement

TL;DR

<b>Sintx Technologies filed an S-1/A amendment on January 24, 2024, for its securities registration.</b>

AI Summary

Sintx Technologies, Inc. (SINT) filed a Amended IPO Registration (S-1/A) with the SEC on January 24, 2024. Sintx Technologies, Inc. filed an amendment (S-1/A) to its registration statement on January 24, 2024. The filing is registered under the Securities Act of 1933, with registration number 333-275137. The company's principal executive offices are located at 1885 West 2100 South, Salt Lake City, UT, 84119. The SIC code for Sintx Technologies is 3841 (Surgical & Medical Instruments & Apparatus). The filing indicates that the company is a non-accelerated filer and a smaller reporting company.

Why It Matters

For investors and stakeholders tracking Sintx Technologies, Inc., this filing contains several important signals. This S-1/A filing is an update to a previous registration statement, indicating ongoing efforts to offer securities to the public. The classification as a 'smaller reporting company' and 'non-accelerated filer' suggests a certain size and reporting status that may influence investor perception and regulatory scrutiny.

Risk Assessment

Risk Level: low — Sintx Technologies, Inc. shows low risk based on this filing. The risk is low as this is a routine amendment to a registration statement, not indicating immediate financial distress or significant operational changes.

Analyst Insight

Monitor future filings for details on the proposed offering and the company's progress in the medical device sector.

Key Numbers

• 333-275137 — Registration Number (S-1/A Filing)
• 3841 — SIC Code (Surgical & Medical Instruments & Apparatus)
• 2024-01-24 — Filing Date (Amendment No. 3 to Form S-1)
• 1231 — Fiscal Year End (Company Data)

Key Players & Entities

• Sintx Technologies, Inc. (company) — Registrant
• B. Sonny Bal, MD (person) — President and Chief Executive Officer
• Dorsey & Whitney LLP (company) — Legal Counsel
• Ellenoff Grossman & Schole LLP (company) — Legal Counsel
• 333-275137 (regulator) — Registration Number
• 1933 Act (regulator) — Securities Act
• 2024-01-24 (date) — Filing Date
• Salt Lake City, UT (location) — Principal Executive Offices

Forward-Looking Statements

• Sintx Technologies will proceed with a public offering of securities. (Sintx Technologies, Inc.) — high confidence, target: Q1-Q2 2024

FAQ

Industry Context

Sintx Technologies operates in the medical instruments and apparatus industry, focusing on advanced ceramic materials for medical applications.

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of securities offered to the public.

What Investors Should Do

1. Review the full S-1/A filing for details on the proposed securities offering.
2. Analyze the company's business description and risk factors within the S-1/A for strategic insights.
3. Track future SEC filings from Sintx Technologies for updates on their financial performance and corporate actions.

Year-Over-Year Comparison

This is an amendment to a previous filing, indicating an update or addition to the initial registration statement.

Key Financial Figures

• $0.298 — at an assumed public offering price of $0.298 per Unit, equal to the closing price of
• $0 — luding one share of common stock, minus $0.0001, and the remaining exercise price
• $0.0001 — e of each pre-funded warrant will equal $0.0001 per share. The pre-funded warrants will
• $0.3125 — rted sale price of our common stock was $0.3125 per share. There is no established publ
• $100,000 — related to the Offering including up to $100,000 for reimbursement of legal expenses in

Filing Documents

• forms-1a.htm (S-1/A) — 998KB
• ex4-17.htm (EX-4.17) — 113KB
• ex4-18.htm (EX-4.18) — 113KB
• ex4-20.htm (EX-4.20) — 154KB
• ex5-1.htm (EX-5.1) — 19KB
• ex23-1.htm (EX-23.1) — 4KB
• ex107.htm (EX-FILING FEES) — 39KB
• 0001493152-24-003612.txt (&nbsp;) — 1443KB

Risk Factors

Risk Factors 7 Special Note Regarding Forward-Looking Statements 13

Use of Proceeds

Use of Proceeds 15 Capitalization 16

Description of Securities

Description of Securities 22 Plan of Distribution 39 Material U.S. Federal Income Tax Consequences 45 Legal Matters 53 Experts 53 Where You Can Find More Information 53 Incorporation By Reference 54 i ABOUT THIS PROSPECTUS The registration statement of which this prospectus forms a part that we have filed with the Securities and Exchange Commission, or SEC, includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC before making your investment decision. You should rely only on the information provided in this prospectus or in a prospectus supplement or any free writing prospectuses or amendments thereto. Neither we nor the placement agent have authorized anyone else to provide you with different information. We do not, and the placement agent and its affiliates do not, take any responsibility for, and can provide no assurance as to the reliability of, any information that others may provide to you. If anyone provides you with different or inconsistent information, you should not rely on it. You should assume that the information in this prospectus is accurate only as of the date hereof, regardless of the time of delivery of this prospectus or any sale of securities. Our business, financial condition, results of operations and prospects may have changed since that date. We are not, and the placement agent is not, offering to sell or seeking offers to purchase these securities in any jurisdiction where the offer or sale is not permitted. We and the placement agent have not done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securiti

View Full Filing

View this S-1/A filing on SEC EDGAR